Home ›
Trademark Categories ›
Pharmaceuticals ›
2002 ›
AD ›
ADVAZULAR
Trademark search for:
ADVAZULAR
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2006-01-23 — Application filed
2006-01-27 — Application filed
2006-06-13 — Assigned to examiner
2006-06-14 — Approved for pub - principal register
2006-06-16 — Assigned to lie
2006-06-29 — Law office publication review completed
2006-08-02 — Notice of publication
2006-08-22 — Published for opposition
2006-11-14 — Noa mailed - sou required from applicant
2007-04-16 — Sou teas extension received
2007-04-16 — Sou extension 1 filed
2007-07-26 — Sou extension 1 granted
2007-10-09 — Sou teas extension received
2007-10-09 — Sou extension 2 filed
2007-10-17 — Sou extension 2 granted
2008-04-16 — Sou teas extension received
2008-04-16 — Sou extension 3 filed
2008-04-25 — Sou extension 3 granted
2008-09-30 — Sou teas extension received
2008-09-30 — Sou extension 4 filed
2008-10-01 — Case assigned to intent to use paralegal
2008-10-01 — Sou extension 4 granted
2009-05-12 — Sou teas extension received
2009-05-12 — Sou extension 5 filed
2009-05-13 — Sou extension 5 granted
2009-12-14 — Application abandoned
2009-12-14 — Application abandoned
2009-12-14 — Final status recorded
Owner Information
Eli Lilly and Company
Indianapolis , IN
Eli Lilly and Company
Indianapolis , IN
Correspondent
Robert E. Lee, Jr. Eli Lilly and Company LILLY CORPORATE CENTER INDIANAPOLIS, IN 46285-0001 UNITED STATES
Filing Details
Filing Date:
2006-01-23
Status Date:
2009-12-14
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.